Cargando…
Programmed death-ligand 1 expression and its correlation with clinicopathological parameters in gallbladder cancer
BACKGROUND: Immunomodulatory therapies targeting the interaction between programmed cell death protein 1 and programmed death-ligand 1 (PD-L1) have become increasingly important in anticancer treatment. Previous research on the subject of this immune response has established an association with tumo...
Autores principales: | Kim, Ji Hye, Kim, Kyungbin, Kim, Misung, Kim, Young Min, Suh, Jae Hee, Cha, Hee Jeong, Choi, Hye Jeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Pathologists and the Korean Society for Cytopathology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093290/ https://www.ncbi.nlm.nih.gov/pubmed/32028754 http://dx.doi.org/10.4132/jptm.2019.11.13 |
Ejemplares similares
-
Primary hepatic extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue
por: Choi, Soyeon, et al.
Publicado: (2020) -
Concurrent Gastric Adenocarcinoma of Fundic Gland Type and Carcinoma with Lymphoid Stroma: A Rare Case Report
por: Cha, Hee Jeong, et al.
Publicado: (2016) -
Clinicopathological and prognostic significance of programmed death ligand-1 expression in breast cancer: a meta-analysis
por: Kim, Hye Min, et al.
Publicado: (2017) -
Programmed Death-Ligand 1 Expression and Its Correlation with Lymph Node Metastasis in Papillary Thyroid Carcinoma
por: An, Hyo Jung, et al.
Publicado: (2018) -
Clinicopathologic Significance and Immunogenomic Analysis of Programmed Death-Ligand 1 (PD-L1) and Programmed Death 1 (PD-1) Expression in Thymic Epithelial Tumors
por: Song, Joon Seon, et al.
Publicado: (2019)